GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Figure 7

Correlation between GPR17 and immune checkpoints in STAD. (a) Heatmap of correlations between GPR17 expression levels and immunoinhibitor in STAD. (b–d) Correlation between GPR17 expression level and immunoinhibitor. (e) Heatmap of correlations between GPR17 expression levels and immunostimulator in STAD. (f–h) Correlation between GPR17 expression level and immunostimulator.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)